semaglutide and inositol Weight Loss Beyond glycemic control: How semaglutide
Description
Second, as MACE was the primary outcome of all included RCTs, stroke meta-analyses were based on secondary outcome assessment
For non-diabetic patients, the primary goal is weight loss rather than blood glucose control
Semaglutide is an FDA-approved medication commonly used to manage type 2 diabetes and promote weight loss
doi: 10.1016/j.jacl.2022.03.007 262 Del PratoSKahnSEPavoIWeerakkodyGJYangZDoupisJet al
